The thoratec® centrimag® for pediatric right ventricular failure

Journal of Extra-Corporeal Technology

Volumn 45, Issue 2, 2013, Pages 133-135

  Hodge, Ashley B ^a   Yeager, Catherine J ^b   Preston, Thomas J ^a   Savage, Andrew J ^c   Butts, Ryan J ^c   Kavarana, Minoo N ^c  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Anticoagulation; Cardiomyopathy; Cardiopulmonary bypass equipment; Pediatric heart failure; Pediatric transplantation; Ventricular assist device

Indexed keywords

ADRENALIN; DOPAMINE; HEPARIN; MILRINONE;

ADOLESCENT; ANTICOAGULATION; ARTICLE; BLOOD PUMP; CANNULATION; CASE REPORT; CHILDHOOD DISEASE; DISEASE SEVERITY; ENDOCARDIAL FIBROELASTOSIS; HEART ATRIUM SEPTUM DEFECT; HEART RIGHT VENTRICLE FAILURE; HEART TRANSPLANTATION; HEART VENTRICLE FUNCTION; HUMAN; INTENSIVE CARE UNIT; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; MALE; POSTOPERATIVE PERIOD; REPEAT PROCEDURE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRICUSPID VALVE REGURGITATION; VENTRICULAR ASSIST DEVICE; CENTRIFUGATION; EQUIPMENT; EQUIPMENT DESIGN; EQUIPMENT FAILURE; EXTRACORPOREAL CIRCULATION; HEART ASSIST DEVICE; HEART RIGHT VENTRICLE FUNCTION; MAGNETISM; PEDIATRICS; TREATMENT OUTCOME;

ADOLESCENT; CENTRIFUGATION; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; EXTRACORPOREAL CIRCULATION; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; MAGNETICS; MALE; PEDIATRICS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84881533326     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. De Robertis F, Rogers P, Amrani M, et al. Bridge to decision using the Levitronix CentriMag short-term ventricular assist device. J Heart Lung Transplant. 2008;27:474-8.
2. Kouretas PC, Kaza AK, Burch PT, et al. Experience with the Levitronix CentriMag in the pediatric population as a bridge to decision and recovery. Artif Organs. 2009;33:1002-4.
3. Santise G, Petrou M, Pepper J, et al. Levitronix as a short-term salvage treatment for primary graft failure after heart transplant. J Heart Lung Transplant. 2006;25:495-8.
4. Sharma MS, Forbess JM, Guleserian KJ. Ventricular assist device support in children and adolescents with heart failure: The Children's Medical Center of Dallas experience. Artif Organs. 2012;36:635-9.
5. Brown KL, Ridout DA, Shaw M, et al. Healthcare-associated infection in pediatric patients on extracorporeal life support: The role of multidisciplinary surveillance. Pediatr Crit Care Med. 2006;7:546-50.
6. Clough RE, Vallely MP, Henein M, Pepper JR. Levitronix ventricular assist device as a bridge-to-recovery for post-cardiotomy cardiogenic shock. Int J Cardiol. 2009;134:408-9.
7. De Robertis F, Birks EJ, Rogers P, et al. Clinical performance with the Levitronix CentriMag short-term ventricular assist device. J Heart Lung Transplant. 2006;25:181-6.
8. John R, Long J, Massey T, et al. Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support. J Thorac Cardiovasc Surg. 2011;141:932-9.
9. Hernandez A, Grab J, Gammie J, et al. A decade of short-term outcomes in post-cardiac surgery ventricular assist device implantation: Data from the Society of Thoracic Surgeons' national cardiac database. Circulation. 2007;116:606-12.
10. Aggarwal A, Modi S, Kumar S, et al. Use of a single-circuit CentriMag® for biventricular support in postpartum cardiomyopathy. Perfusion. 2013;28:156-9.
11. Stiller B, Lemmer J, Schubert S, et al. Management of pediatric patients after implantation of the Berlin Heart EXCOR ventricular assist device. ASAIO J. 2006;52:497-500.
12. Hetzer R, Stiller B. Technology Insight: Use of ventricular assist devices in children. Nat Clin Pract Cardiovasc Med. 2006;3:377-86.